Overactive Bladder - Results from #2060

REVIEW UroToday

A review and additional post-hoc analyses of the incidence and impact of constipation observed in darifenacin clinical trials - Abstract October 18, 2012

Trospium chloride once daily for overactive bladder syndrome : Results of a multicenter observational study - Abstract October 16, 2012

Aging and recurrent urinary tract infections are associated with bladder dysfunction in type 2 diabetes - Abstract October 15, 2012

Is there a direct antimicrobial effect of botulinum neurotoxin type A? - Abstract October 11, 2012

Leptin - a novel pharmacological agent for treatment of women with overactive bladder symptoms? - Abstract October 9, 2012

New study demonstrates superior clinical and quality of life benefits of Medtronic sacral neuromodulation compared to standard medical treatment for overactive bladder at six months October 9, 2012

Finding unrecognized information in overactive bladder clinical trial data: A new approach to understanding placebo and treatment effects - Abstract October 5, 2012

Efficacy and adverse events of antimuscarinics for treating overactive bladder: Network meta-analyses - Abstract October 5, 2012

AUGS 2012 - Evaluation of the quality of life improvements at six months in subjects with overactive bladder randomized to Interstim® therapy implant versus standard medical therapy - Session Highlights October 4, 2012

How dry is "OAB-Dry"? Perspectives from patients and physician experts - Abstract October 3, 2012

Cost-effectiveness analysis of antimuscarinic agents for the treatment of overactive bladder - Abstract October 2, 2012

Immunological and viral features in patients with overactive bladder associated with human T-cell lymphotropic virus type 1 infection - Abstract October 1, 2012

Onabotulinum toxin A for the treatment of neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosis - Abstract September 28, 2012

Detrusor myectomy: Long-term functional outcomes - Abstract September 27, 2012

Intradetrusor versus suburothelial onabotulinumtoxinA injections for neurogenic detrusor overactivity: A pilot study - Abstract September 26, 2012

Test - retest reliability of the Indonesian version of the Overactive Bladder Symptom Score (OABSS) and its correlation with standard assessment tools - Abstract September 25, 2012

Oxybutynin: Past, present, and future - Abstract September 24, 2012

Correlation of ultrasound-estimated bladder weight to urodynamic diagnoses in women with lower urinary tract symptoms - Abstract September 20, 2012

Intradetrusor injection of botulinum toxin for the management of refractory overactive bladder syndrome: An update - Abstract September 19, 2012

Urodynamic differences between dysfunctional voiding and primary bladder neck obstruction in women - Abstract September 18, 2012

Page 104 of 121